Description of sociodemographic and clinical characteristics
Variables
N (%)
Age
< 50 years
26 (38.8)
≥ 50 years
41 (61.2)
Gender
Male
15 (22.4)
Female
52 (77.6)
Habitat
Rural
49 (76.6)
Urban
15 (23.4)
Marital status
Married
40 (75.5)
Unmarried
13 (24.5)
Level of education
Illiterate
34 (77.3)
Literate
10 (22.7)
Profession
Unemployed
24 (54.5)
Employed
20 (45.5)
Lives
Alone
4 (7.1)
With family
52 (92.9)
Step
I or II
10 (17.9)
III or IV
46 (82.1)
Level of control
Well controlled
37 (66.1)
Poorly controlled
19 (33.9)
Comorbidity
Hypertension
10 (14.9)
Diabetes
10 (14.9)
Cardiac disease
7 (10.4)
Surgical antecedents
17 (25.8)
Smokers/ex-smokers
10 (14.9)
Cough
27 (40.3)
Dyspnea stage mMRC ≥ 2
18 (26.9)
Cyanosis
8 (14.0)
Sputum
15 (22.4)
Wheezing
30 (44.8)
Pain
6 (9.0)
Hemoptysis
6 (9.0)
Infection
14 (20.9)
Fatigue
16 (23.9)
Weight loss
11 (16.4)
Anorexia
8 (11.9)
Patient under oxygen therapy
Yes
6 (9.0)
No
61 (91.0)
Number of treatments
< 2
20 (29.9)
≥ 2
47 (70.1)
Number of exacerbations
< 2/year
39 (58.2)
≥ 2/year
28 (41.8)
Number of hospitalizations
< 2/year
59 (88.1)
≥ 2/year
8 (11.9)
Duration of disease: mean (± SD)
11.9 ± 8.8
FEV1: mean (± SD)
1.7 ± 0.8
The missing data are due to non-responders and potential input errors or incomplete information from medical records. FEV1: forced expiratory volume in 1 second; mMRC: Modified Medical Research Council Dyspnoea Scale
Declarations
Author contributions
NB: Methodology, Data curation, Formal analysis, Writing—original draft, Supervision. BA, NO, NT, MB, MS, MCB: Writing—review & editing. SEY, HB: Data curation. SEF: Conceptualization, Investigation, Writing—review & editing. All authors read and approved the submitted version.
Conflicts of interest
The authors declare that they have no conflicts of interest.
Ethical approval
The study was approved by the Hassan II University Hospital Ethics Committee, Fez, [Reference: 26/18].
Consent to participate
Informed consent to participate in the study was obtained from all participants.
Consent to publication
Not applicable.
Availability of data and materials
Data for public use is no longer available. The confidential data analyzed in this study can be obtained upon request at nassibabahra@gmail.com.
Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.
Song P, Adeloye D, Salim H, Santos JPD, Campbell H, Sheikh A, et al. Global, regional, and national prevalence of asthma in 2019: a systematic analysis and modelling study.J Glob Health. 2022;12:04052. [DOI] [PubMed] [PMC]
Li Y, Wang P, Shao X, Peng F, Lv D, Du H, et al. Asthma prevalence based on the Baidu index and China's Health Statistical Yearbook from 2011 to 2020 in China.Front Public Health. 2023;11:1221852. [DOI] [PubMed] [PMC]
Wang Y, Guo D, Chen X, Wang S, Hu J, Liu X. Trends in asthma among adults in the United States, National Health and Nutrition Examination Survey 2005 to 2018.Ann Allergy Asthma Immunol. 2022;129:71–8.e2. [DOI] [PubMed]
Tarraf H, Aydin O, Mungan D, Albader M, Mahboub B, Doble A, et al. Prevalence of asthma among the adult general population of five Middle Eastern countries: results of the SNAPSHOT program.BMC Pulm Med. 2018;18:68. [DOI] [PubMed] [PMC]
Muanprasong S, Taneepanichskul N. Improving asthma management and enhancing quality of life for adults in Thailand.IJIRSS. 2024;7:1491–8. [DOI]
Ahmed NH, Elsalam SNA, Mohamed IA. Health Related Quality of Life for Patients with Bronchial Asthma.Egypt J Health Care. 2024;15:141–54. [DOI]
Karsaneh OAA, Anber AA, Shboul SA, Alrjoub M, Almashaqbeh OI, Alqaisi M, et al. Impact of Anxiety and Depression on the Level of Asthma Control Among Jordanian Adults with Asthma.J Asthma Allergy. 2024;17:463–76. [DOI] [PubMed] [PMC]
Chaisuksant S, Somruesaen T, Khamsai S, Sawanyawisuth K. Anxiety and depression in patients with asthma in Thailand.Gazzetta Medica Italiana. 2024;183:305–9. [DOI]
Cunha MS, Amaral R, Pereira AM, Almeida R, Alves-Correia M, Loureiro CC, et al. Symptoms of anxiety and depression in patients with persistent asthma: a cross-sectional analysis of the INSPIRERS studies.BMJ Open. 2023;13:e068725. [DOI] [PubMed] [PMC]
2022 GINA Main Report [Internet].Global Initiative for Asthma; c2025 [cited 24 Dec 2024]. Available from: https://ginasthma.org/gina-reports/
Ware J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity.Med Care. 1996;34:220–33. [DOI] [PubMed]
Obtel M, Rhazi K, Elhold S, Benjelloune M, Gnatiuc L, Nejjari C. Cross-cultural adaptation of the 12-Item Short-Form survey instrument in a Moroccan representative Survey.South Afr J Epidemiol Infect. 2013;28:166–71. [DOI]
Jr JEW, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.Med Care. 1992;30:473–83. [PubMed]
Ware J, Kosinski M, Turner-Bowker D, Gandek B. How to score SF-12 items. SF-12 v2: How to Score Version 2 of the SF-12 Health Survey.JANV. 2002;2938.
Wang DY, Ghoshal AG, Bin Abdul Muttalif AR, Lin HC, Thanaviratananich S, Bagga S, et al. Quality of Life and Economic Burden of Respiratory Disease in Asia-Pacific-Asia-Pacific Burden of Respiratory Diseases Study.Value Health Reg Issues. 2016;9:72–7. [DOI] [PubMed]
Bendahhou K, Serhir Z, Ibrahim Khalil A, Radallah D, Amegrissi S, Battas O, et al. Validation de la version dialectale Marocaine de l’échelle «HADS».Rev Epidemiol Sante Publique. 2017;65:S53. [DOI]
Zigmond AS, Snaith RP. The hospital anxiety and depression scale.Acta Psychiatr Scand. 1983;67:361–70. [DOI] [PubMed]
Botega NJ, Bio MR, Zomignani MA, Jr CG, Pereira WA. Mood disorders among medical in-patients: a validation study of the hospital anxiety and depression scale (HAD).Rev Saude Publica. 1995;29:355–63. [DOI] [PubMed]
Rabelo LM, Jaques SC, Szlichta L de L, Bessa MA do SMR. Prevalência de transtorno de depressão e ansiedade em pacientes com asma grave / Prevalence of depression and anxiety disorders in patients with severe asthma.Arq Med Hosp Fac Cienc Med Santa Casa São Paulo. 2024;69:e9. [DOI]
Laumet G, Edralin JD, Dantzer R, Heijnen CJ, Kavelaars A. CD3+ T cells are critical for the resolution of comorbid inflammatory pain and depression-like behavior.Neurobiol Pain. 2020;7:100043. [DOI] [PubMed] [PMC]
Tribuntceva LV, Васильевна ТЛ, Budnevsky AV, Валериевич БА, Prozorova GG, Гаральдовна ПГ, et al. Quality of life of patients with asthma: the effects of overweight, obesity and multimorbidity.Russian Family Doctor. 2024;28:5160. [DOI]
